HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].

Abstract
Patients with chronic obstructive pulmonary diseases (COPD) are frequently exposed to infectious agents including influenza virus and Streptococcus pneumoniae. These infectious agents cause pneumonia and exacerbation of COPD. Prevention as well as anti-microbial treatments is critical for COPD. International guideline recommends that all COPD patients should be vaccinated against influenza virus. While pneumococcal vaccine is recommended for older and severe cases at present. Recently additive effect of pneumococcal vaccine and influenza vaccine are shown.
AuthorsHiroto Matsuse
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 74 Issue 5 Pg. 839-42 (May 2016) ISSN: 0047-1852 [Print] Japan
PMID27254956 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Influenza Vaccines
  • Pneumococcal Vaccines
Topics
  • Disease Progression
  • Humans
  • Influenza Vaccines
  • Influenza, Human (complications, prevention & control)
  • Pneumococcal Vaccines
  • Pneumonia, Pneumococcal (complications, prevention & control)
  • Practice Guidelines as Topic
  • Pulmonary Disease, Chronic Obstructive (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: